TrianglePUBLICATIONS · 34115544
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Oct 20
- First author
- Bellini A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Bellini A
- type
- Author
- name
- Pötschger U
- type
- Author
- name
- Bernard V
- type
- Author
- name
- Lapouble E
- type
- Author
- name
- Baulande S
- type
- Author
- name
- Ambros PF
- type
- Author
- name
- Auger N
- type
- Author
- name
- Beiske K
- type
- Author
- name
- Bernkopf M
- type
- Author
- name
- Betts DR
- type
- Author
- name
- Bhalshankar J
- type
- Author
- name
- Bown N
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Bellini A
- type
- Author
- name
- Pötschger U
- type
- Author
- name
- Bernard V
- type
- Author
- name
- Lapouble E
- type
- Author
- name
- Baulande S
- type
- Author
- name
- Ambros PF
- type
- Author
- name
- Auger N
- type
- Author
- name
- Beiske K
- type
- Author
- name
- Bernkopf M
- type
- Author
- name
- Betts DR
- type
- Author
- name
- Bhalshankar J
- type
- Author
- name
- Bown N
- type
- Author
- bibliography ids
- nci-bib-50d8c8f9b7f530bb80da14e0
- book metadata
- content sha256
- 48f2adcc662bfbde3ea728be21fc54823bf09b93d833421424405e4449cfa9b4
- document type
- citation
- dois
- 10.1200/JCO.21.00086
- electronic publication date
- display
- 2021 Jun 11
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34115544
- immutable id
- pubmed:34115544@48f2adcc662bfbde3ea728be21fc54823bf09b93d833421424405e4449cfa9b4
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 30
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3377-3390
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 34115544
- provenance
- batch id
- 79f1021053e858d13ff3
- provider
- NCBI PubMed ESummary
- record sha256
- 5dbb5f09c57a615e723c55fb80c18d2b74b83192b9da5d8ada3bd9f16a8397bf
- response sha256
- 671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
- retrieved at
- 2026-09-09T23:47:59.098265+00:00
- publication date
- display
- 2021 Oct 20
- precision
- day
- year
- 2021
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Preserved source evidence · Independent clinical review pending · Not medical advice